Privately-held clinical stage Montreal-based biotechnology company. Engaged in the discovery and development of therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. Currently, having one program with Phase I data. Portfolio of highly-specific, novel and clinically-relevant targets using the proprietary STAR technology. Exploiting a powerful a proprietary target discovery technology with th...
Privately-held clinical stage Montreal-based biotechnology company. Engaged in the discovery and development of therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. Currently, having one program with Phase I data. Portfolio of highly-specific, novel and clinically-relevant targets using the proprietary STAR technology. Exploiting a powerful a proprietary target discovery technology with the potential to expand pipeline
Established strategic partnerships to to access mAb generation, humanization, antibody drug conjugates, and CHO production technologies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.